TARGETED THERAPY FOR MAP3K1 AND MAP2K4 MUTANT ESTROGEN RECEPTOR-POSITIVE BREAST CANCER

$236,501FY2012Department of the ArmyDOD

University Of North Carolina At Chapel Hill, Chapel Hill NC

Investigators